Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -5.119M
March 31, 2026 -18.11M
December 31, 2025 -16.44M
September 30, 2025 -41.25M
June 30, 2025 -5.655M
March 31, 2025 -13.89M
December 31, 2024 -4.302M
September 30, 2024 -5.747M
June 30, 2024 -4.951M
March 31, 2024 -20.16M
December 31, 2023 -5.984M
September 30, 2023 -3.866M
June 30, 2023 1.033M
March 31, 2023 -9.824M
December 31, 2022 -4.429M
September 30, 2022 -14.55M
June 30, 2022 -7.94M
March 31, 2022 -21.70M
December 31, 2021 -10.29M
September 30, 2021 -13.78M
June 30, 2021 -9.749M
Date Value
March 31, 2021 -14.09M
December 31, 2020 4.654M
September 30, 2020 -7.419M
June 30, 2020 -7.421M
March 31, 2020 -13.18M
December 31, 2019 -4.535M
September 30, 2019 -8.832M
June 30, 2019 -7.468M
March 31, 2019 -5.352M
December 31, 2018 -8.108M
September 30, 2018 -6.643M
June 30, 2018 -3.909M
March 31, 2018 -10.06M
December 31, 2017 -4.402M
September 30, 2017 -7.485M
June 30, 2017 -6.227M
March 31, 2017 -3.992M
December 31, 2016 -4.188M
September 30, 2016 -5.828M
June 30, 2016 -4.809M
March 31, 2016 -2.917M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -2.189M
Codexis, Inc. -9.643M
Frontage Holdings Corp. --
Repligen Corp. 32.77M
Bio-Techne Corp. 95.42M